AVITA Medical (AVHHL) Shares Outstanding (Diluted Average) (2018 - 2025)
AVITA Medical (AVHHL) reported Shares Outstanding (Diluted Average) of $27.9 million for Q4 2025, up 7.64% on a YoY basis from $25.9 million in Q4 2024, and up 3.14% quarter-over-quarter from $27.0 million in Q3 2025.
AVITA Medical (AVHHL) Shares Outstanding (Diluted Average) (2018 - 2025) Analysis & Trends
AVITA Medical has reported Shares Outstanding (Diluted Average) for 8 years, with the latest figure at $27.9 million in Q4 2025.
- For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) rose 7.64% year-over-year to $27.9 million; the trailing twelve-month figure through Dec 2025 stood at $27.9 million (up 7.64% YoY), and the FY2025 full-year result was $27.9 million, up 7.64% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2025 stood at $27.9 million, up from $27.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $27.9 million in Q4 2025, with the low at $22.7 million in Q2 2021.
- Historically, Shares Outstanding (Diluted Average) has averaged $25.3 million across 5 years, with a median of $25.3 million in 2023.
- Annual changes were most pronounced in 2021 — Shares Outstanding (Diluted Average) increased 15.22% — and 2022, when it increased 0.34%.
- AVITA Medical's Shares Outstanding (Diluted Average) stood at $24.9 million in 2021, then grew by 0.34% to $25.0 million in 2022, then gained by 1.32% to $25.3 million in 2023, then grew by 2.18% to $25.9 million in 2024, then advanced by 7.64% to $27.9 million in 2025.
- The last three Shares Outstanding (Diluted Average) figures came in at $27.9 million (Q4 2025), $27.0 million (Q3 2025), and $26.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | AVITA Medical | - | - | 14.31 Mn | 27.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 27.86 Mn |
| Sep 30, 2025 | 27.01 Mn |
| Jun 30, 2025 | 26.37 Mn |
| Mar 31, 2025 | 26.25 Mn |
| Dec 31, 2024 | 25.88 Mn |
| Sep 30, 2024 | 25.98 Mn |
| Jun 30, 2024 | 25.76 Mn |
| Mar 31, 2024 | 25.64 Mn |
| Dec 31, 2023 | 25.33 Mn |
| Sep 30, 2023 | 25.40 Mn |
| Jun 30, 2023 | 25.22 Mn |
| Mar 31, 2023 | 25.20 Mn |
| Dec 31, 2022 | 25.00 Mn |
| Sep 30, 2022 | 24.97 Mn |
| Jun 30, 2022 | 24.97 Mn |
| Mar 31, 2022 | 24.94 Mn |
| Dec 31, 2021 | 24.92 Mn |
| Sep 30, 2021 | 24.17 Mn |
| Jun 30, 2021 | 22.67 Mn |
| Mar 31, 2021 | 22.73 Mn |